144 related articles for article (PubMed ID: 6172171)
21. [Interpretation of minimal medullary plasmacytoses in monoclonal dysglobulinemias. Importance of the study of osteomedullary biopsies of semi-thin sections and immunologic marking].
Canioni D; Kermarec J
Ann Pathol; 1982; 2(4):279-92. PubMed ID: 6760876
[TBL] [Abstract][Full Text] [Related]
22. Multiple myeloma plasma cell kinetics: rapid and reliable evaluation using 5-bromo-2-deoxyuridine (BrdUrd) DNA incorporation detected by an anti-BrdUrd monoclonal antibody.
Boccadoro M; Redoglio V; Gavarotti P; Pileri A
Tumori; 1986 Apr; 72(2):135-7. PubMed ID: 3705185
[TBL] [Abstract][Full Text] [Related]
23. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A
J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842
[TBL] [Abstract][Full Text] [Related]
24. ["Benign" monoclonal gammopathy: prognostic value of initial bone marrow study].
Grau E; Ayats R; Puig J; Domingo A; Pujol-Moix N
Sangre (Barc); 1985; 30(3):308-19. PubMed ID: 4035526
[No Abstract] [Full Text] [Related]
25. Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis.
Greipp PR
Blood Rev; 1989 Dec; 3(4):222-36. PubMed ID: 2482097
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of the MB2 monoclonal antibody in paraffin-embedded bone marrow sections of patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Dehou MF; Schots R; Lacor P; Arras N; Verhavert P; Klöppel G; van Camp B
Am J Clin Pathol; 1990 Sep; 94(3):287-91. PubMed ID: 1697732
[TBL] [Abstract][Full Text] [Related]
27. Serum beta 2-microglobulin, serum creatinine and bone marrow plasma cells in benign and malignant monoclonal gammopathy.
Morell A; Riesen W
Acta Haematol; 1980; 64(2):87-93. PubMed ID: 6159767
[TBL] [Abstract][Full Text] [Related]
28. Intranuclear inclusions in plasma cells and lymphocytes from patients with monoclonal gammopathies.
Brunning RD; Parkin J
Am J Clin Pathol; 1976 Jul; 66(1):10-21. PubMed ID: 820183
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma.
Barlogie B; Alexanian R; Dixon D; Smith L; Smallwood L; Delasalle K
Blood; 1985 Aug; 66(2):338-41. PubMed ID: 2410065
[TBL] [Abstract][Full Text] [Related]
30. Ploidy status rarely changes in myeloma patients at disease progression.
Chng WJ; Winkler JM; Greipp PR; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Ahmann GJ; Henderson K; Blood E; Oken MM; Hulbert A; Van Wier SA; Santana-Dávila R; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Fonseca R
Leuk Res; 2006 Mar; 30(3):266-71. PubMed ID: 16111750
[TBL] [Abstract][Full Text] [Related]
31. Conventional diagnostics in multiple myeloma.
San Miguel JF; Gutiérrez NC; Mateo G; Orfao A
Eur J Cancer; 2006 Jul; 42(11):1510-9. PubMed ID: 16762540
[TBL] [Abstract][Full Text] [Related]
32. 'Benign' monoclonal gammopathy. A misnomer?
Kyle RA
JAMA; 1984 Apr; 251(14):1849-54. PubMed ID: 6422066
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of ploidy and proliferative activity in human solid tumors.
Barlogie B; Johnston DA; Smallwood L; Raber MN; Maddox AM; Latreille J; Swartzendruber DE; Drewinko B
Cancer Genet Cytogenet; 1982 May; 6(1):17-28. PubMed ID: 7104984
[TBL] [Abstract][Full Text] [Related]
34. DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma.
Leo E; Kropff M; Lindemann A; Steinfurth G; Esselborn H; Rossner R; Adler CP; Böcking A
Anal Quant Cytol Histol; 1995 Apr; 17(2):113-20. PubMed ID: 7612131
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Castelano-Leonés (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.
García-Sanz R; Orfão A; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Br J Haematol; 1995 May; 90(1):106-12. PubMed ID: 7786771
[TBL] [Abstract][Full Text] [Related]
37. Analysis of human myeloma cell population kinetics.
Montecucco C; Riccardi A; Ucci G; Danova M; Carnevale R; Caporali R; Longhi M; Luoni R
Acta Haematol; 1986; 75(3):153-6. PubMed ID: 3092531
[TBL] [Abstract][Full Text] [Related]
38. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric analysis of DNA indices, expression of p53 and multidrug resistance genes in multiple myeloma patients.
Kumar V; Varma N; Varma S; Vohra H; Malhotra P; Dutta U; Sharma SC
Anal Quant Cytol Histol; 2004 Oct; 26(5):271-7. PubMed ID: 15560533
[TBL] [Abstract][Full Text] [Related]
40. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
Kumar S; Rajkumar SV; Greipp PR; Witzig TE
Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
